The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 20 April 2004, www.theannals.com, DOI 10.1345/aph.1D461.
 The Annals of Pharmacotherapy: Vol. 38, No. 6, pp. 1070-1073. DOI 10.1345/aph.1D461
© 2004 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Townsend, K. A
Right arrow Articles by Marlowe, K. F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Townsend, K. A
Right arrow Articles by Marlowe, K. F

DRUG INFORMATION ROUNDS

Relative Safety and Efficacy of Finasteride for Treatment of Hirsutism

Kara A Townsend, PharmD

Assistant Clinical Professor, Auburn University, Harrison School of Pharmacy; Adjunct Assistant Professor, Department of Family Practice, University of South Alabama, Mobile, AL

Karen F Marlowe, PharmD BCPS

Assistant Clinical Professor, Auburn University, Harrison School of Pharmacy; Adjunct Assistant Professor, Department of Internal Medicine, University of South Alabama

Reprints: Kara A Townsend PharmD, Auburn University, Harrison School of Pharmacy, 1504 Springhill Ave., Suite 1800, Mobile, AL 36604-3273, fax 251/434-3985, townska{at}auburn.edu

OBJECTIVE: To evaluate the relative safety and efficacy of finasteride for treatment of hirsutism related to hyperandrogenism in women.

DATA SOURCES: Literature retrieval was accessed through MEDLINE (1966–March 2003) using the terms finasteride and hirsutism. Additional information was obtained from the drug manufacturer.

DATA SYNTHESIS: Finasteride has been evaluated for treatment of hirsutism in multiple observational and randomized trials. Finasteride lowered hirsutism scores by 30–60% in most trials, as well as decreasing average hair diameter. In comparative trials, finasteride demonstrated efficacy similar to that of other antiandrogens, with fewer adverse effects.

CONCLUSIONS: Finasteride does reduce the overall hair diameter and number in androgen-sensitive areas. Reported adverse effects have been minimal. Concern over potential teratogenicity and lack of long-term safety information leave finasteride a secondary treatment option for hirsutism.

Key Words: antiandrogens, finasteride, hirsutism

Published Online, April 20, 2004. www.theannals.com, DOI 10.1345/aph.1D461


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
K. A. Martin, R. J. Chang, D. A. Ehrmann, L. Ibanez, R. A. Lobo, R. L. Rosenfield, J. Shapiro, V. M. Montori, and B. A. Swiglo
Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1105 - 1120.
[Abstract] [Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 2004 by Harvey Whitney Books Company.